Admission fasting blood glucose predicts 30‐day poor outcome in patients hospitalized for COVID ‐19 pneumonia-Reference-Cited by-同舟云学术

Admission fasting blood glucose predicts 30‐day poor outcome in patients hospitalized for COVID ‐19 pneumonia

Published:2020-08-04 Issue:10 Volume:22 Page:1955-1957
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Zhang Bin¹,Liu Shuyi¹,Zhang Lu¹,Dong Yuhao²,Zhang Shuixing¹^ORCID

Affiliation:

1. Department of Radiology The First Affiliated Hospital of Jinan University Guangzhou China

2. Department of Catheterization Lab Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou China

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14132

Reference17 articles.

1. World Health Organization.Coronavirus disease 2019 (COVID‐19) Situation Report –155.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed June 25 2020.

2. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention;Wu Z;JAMA,2020

3. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen N;Lancet,2020

4. Prediction for progression risk in patients with COVID‐19 pneumonia: the CALL score;Ji D;Clin Infect Dis,2020

5. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID‐19;Liang W;JAMA Intern Med,2020

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stress hyperglycemia is associated with disease severity in COVID-19;Endokrynologia Polska;2023-10-30

2. Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients;Scientific Reports;2023-10-27

3. Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: gliclazide MR use in the hospital and metabolic status at the posthospital stage;Diabetes mellitus;2023-07-14

4. Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors;Viruses;2023-01-07

5. Assessment of laboratory parameters at various COVID-19 phases in patients with gastrointestinal symptoms;Dokazatel'naya gastroenterologiya;2023